ACADIA Pharmaceuticals (MEX:ACAD) Inventory Turnover: 0.75 (As of Mar. 2026)

What is ACADIA Pharmaceuticals Inventory Turnover?

ACADIA Pharmaceuticals MEX:ACAD 73 Inventory Turnover is 0.75 as of Mar. 2026. GuruFocus rates MEX:ACAD with a GF Score™ of 73/100 and a GF Value™ of MXN357.85 (Fairly Valued). The stock has 9 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. ACADIA Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2026 was MXN447 Mil. ACADIA Pharmaceuticals's Average Total Inventories for the quarter that ended in Mar. 2026 was MXN597 Mil. ACADIA Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.75.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. ACADIA Pharmaceuticals's Days Inventory for the three months ended in Mar. 2026 was 121.82.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. ACADIA Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.12.

ACADIA Pharmaceuticals (MEX:ACAD) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ACADIA Pharmaceuticals's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	596.811	/	447.049	*	365 / 4
	=	121.82

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ACADIA Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	596.811	/	4833.882
	=	0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

ACADIA Pharmaceuticals Inventory Turnover Related Terms

ACADIA Pharmaceuticals Inventory Turnover Historical Data

* Premium members only.

The historical data trend for ACADIA Pharmaceuticals's Inventory Turnover can be seen below:

ACADIA Pharmaceuticals Inventory Turnover Chart

ACADIA Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

2.22

1.36

1.92

3.20

2.96

ACADIA Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.90	0.81	0.77	0.82	0.75

73GF Score

ACADIA Pharmaceuticals Inc MEX:ACAD

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ACADIA Pharmaceuticals Inventory Turnover Calculation

ACADIA Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	1602.472	/ (	(457.762	+	624.258)	/	2 )
=	1602.472	/	541.01
=	2.96

ACADIA Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	447.049	/ (	(624.258	+	569.364)	/	2 )
=	447.049	/	596.811
=	0.75

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.75 mean?

ACADIA Pharmaceuticals (MEX:ACAD) has a Inventory Turnover of 0.75 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on ACADIA Pharmaceuticals and its competitors.

Is ACADIA Pharmaceuticals' Inventory Turnover too high?

ACADIA Pharmaceuticals' current Inventory Turnover is 0.75. Overall, ACADIA Pharmaceuticals has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does ACADIA Pharmaceuticals' Inventory Turnover compare to VKTX and EWTX?

ACADIA Pharmaceuticals' Inventory Turnover of 0.75 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on ACADIA Pharmaceuticals and its competitors. ACADIA Pharmaceuticals's current Inventory Turnover is 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ACADIA Pharmaceuticals stock overvalued right now?

Based on GuruFocus' analysis, ACADIA Pharmaceuticals (MEX:ACAD) is currently considered Fairly Valued. The stock's GF Value™ is MXN357.85, compared to a current price of MXN362.00 — trading 1.2% above its estimated fair value. The current Inventory Turnover is 0.75. ACADIA Pharmaceuticals' overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For ACADIA Pharmaceuticals (MEX:ACAD), the current Inventory Turnover is 0.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACADIA Pharmaceuticals (MEX:ACAD) Overvalued in 2026?

Based on GuruFocus' analysis, ACADIA Pharmaceuticals stock appears to be overvalued. The current stock price of MXN362.00 is trading 1.2% above its estimated GF Value™ of MXN357.85. GuruFocus considers ACADIA Pharmaceuticals to be Fairly Valued.

Key valuation signals for MEX:ACAD:

Inventory Turnover: 0.75
GF Value™: MXN357.85 vs. price of MXN362.00 (1.2% above fair value)
GF Score™: 73/100 with 9 warning signs

No single metric tells the full story. See the MEX:ACAD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ACADIA Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies VKTX EWTX DNLI RLAY RCUS NAMS CRNX CPRX CELC ERAS VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges ACAD:USA DR6:Germany

Address 12830 El Camino Real, Suite 400, San Diego, CA, USA, 92130

Website https://www.acadia.com

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-211, ACP-711, ACP-2591, etc.

73GF Score

Get the complete analysis for MEX:ACAD

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN362.00

Price

MXN357.85

GF Value

View MEX:ACAD Analysis

See Inventory Turnover data for all stocks →